Scarica l'app Stockscreener
11.00
2.40%
-0.27
Dopo l'orario di chiusura:
11.00
Panoramica
Notizia
Cronologia dei prezzi
Financials
Perché RNAZ Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$11.27
Aprire:
$11.55
Volume 24 ore:
148.73K
Relative Volume:
1.01
Capitalizzazione di mercato:
$9.17M
Reddito:
-
Utile/perdita netta:
$-14.93M
Rapporto P/E:
-0.0413
EPS:
-266.137
Flusso di cassa netto:
$-15.87M
1 W Prestazione:
+9.45%
1M Prestazione:
+41.21%
6M Prestazione:
-94.42%
1 anno Prestazione:
-96.03%
Intervallo 1D:
$10.80
$12.43
Intervallo di 1 settimana:
$9.02
$13.47
Portata 52W:
$6.1478
$739.20
Transcode Therapeutics Inc Stock (RNAZ) Company Profile
Nome
Transcode Therapeutics Inc
Settore
Industria
Telefono
857-301-6857
Indirizzo
6 LIBERTY SQUARE, BOSTON
Confronta RNAZ con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RNAZ
Transcode Therapeutics Inc
|
11.00 | 9.40M | 0 | -14.93M | -15.87M | -266.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Transcode Therapeutics Inc Borsa (RNAZ) Ultime notizie
RNAZ’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com
What drives TransCode Therapeutics Inc. stock priceFree Predictions - Autocar Professional
What analysts say about TransCode Therapeutics Inc. stockPhenomenal returns - Autocar Professional
TransCode Therapeutics Inc. Stock Analysis and ForecastAccelerated earnings growth - jammulinksnews.com
(RNAZ) On The My Stocks Page - news.stocktradersdaily.com
Is TransCode Therapeutics Inc. a good long term investmentBreakthrough financial growth - jammulinksnews.com
TransCode Therapeutics (NASDAQ:RNAZ) Upgraded at Wall Street Zen - Defense World
Will TransCode Therapeutics Inc. stock benefit from interest rate changesPotential Rocket List - Newser
What analysts say about CleanCore Solutions Inc. stock outlookSecure Your Capital Strategy - Newser
Is SS Innovations International Inc. stock a good hedge against inflationGroup Only Stock Signals - Newser
Why TransCode Therapeutics Inc. stock attracts strong analyst attentionSmart Money Trade Setups - Newser
RNAZ SEC FilingsTranscode Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
What makes TransCode Therapeutics Inc. stock price move sharplyFree Group Entry - Newser
How TransCode Therapeutics Inc. stock performs during market volatilityFree Stock Market Entry & Exit Signals - Newser
When (RNAZ) Moves Investors should Listen - news.stocktradersdaily.com
TransCode Therapeutics (NASDAQ:RNAZ) Trading 14.9% Higher – Should You Buy? - Defense World
STP(showtime potocol) News and UpdatesHigh Return Setup Scanner - Newser
(RNAZ) Technical Pivots with Risk Controls - news.stocktradersdaily.com
Head-To-Head Analysis: TransCode Therapeutics (NASDAQ:RNAZ) vs. Silence Therapeutics (NASDAQ:SLN) - Defense World
(RNAZ) Proactive Strategies - news.stocktradersdaily.com
TransCode Therapeutics (NASDAQ:RNAZ) Trading 4.7% Higher – Here’s Why - Defense World
TransCode Therapeutics Announces 2025 Annual Meeting Date - TipRanks
(RNAZ) Investment Analysis - news.stocktradersdaily.com
Pre-market Movers: BDTX, CRGX, PASG, RGC... - RTTNews
Transcode Therapeutics Appoints Dr. Phillip D. Zamore To Science Advisory Board - marketscreener.com
TransCode Therapeutics Appoints Dr. Phillip D. Zamore to Science Advisory Board - citybiz
TransCode Therapeutics appoints RNA expert to advisory board - Investing.com
TransCode Therapeutics appoints RNA expert to advisory board By Investing.com - Investing.com Nigeria
Transcode Therapeutics Inc Azioni (RNAZ) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.32%
1.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):